These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7585323)

  • 21. The renin-angiotensin-aldosterone system: a specific target for hypertension management.
    Weir MR; Dzau VJ
    Am J Hypertens; 1999 Dec; 12(12 Pt 3):205S-213S. PubMed ID: 10619573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelium-dependent regulation of resistance arteries: alterations with aging and hypertension.
    Lüscher TF; Dohi Y; Tschudi M
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S34-42. PubMed ID: 1381793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of long-term slow-pressor and subpressor angiotensin II on contractile and relaxant reactivity of resistance versus conductance arteries.
    Kopf PG; Phelps LE; Schupbach CD; Johnson AK; Peuler JD
    Physiol Rep; 2018 Mar; 6(5):. PubMed ID: 29504268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors.
    Goto K; Fujii K; Kansui Y; Iida M
    Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):650-5. PubMed ID: 15479174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New aspects of the pathophysiology and pathogenesis of arterial hypertension--a review of the literature].
    Franz C; Linss G; Franz N
    Z Gesamte Inn Med; 1990 Dec; 45(24):723-8. PubMed ID: 2151671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular effects of perindopril: from experimental to clinical investigation.
    Scalbert E; Levy B; Desche P; Devissaguet M; Safar ME
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S25-32. PubMed ID: 1725197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of angiotensin II in the remodeling induced by a chronic decrease in blood flow in rat mesenteric resistance arteries.
    Baron-Menguy C; Toutain B; Cousin M; Dumont O; Guihot AL; Vessières E; Subra JF; Custaud MA; Loufrani L; Henrion D
    Hypertens Res; 2010 Aug; 33(8):857-66. PubMed ID: 20535114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium antagonists and ACE inhibitors. Effect on endothelium and vascular smooth muscle.
    Lüscher TF; Yang Z
    Drugs; 1993; 46 Suppl 2():121-32. PubMed ID: 7512465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of Vascular Myogenic Tone in miR-143/145 Knockout Mice Is Associated With Hypertension-Induced Vascular Lesions in Small Mesenteric Arteries.
    Holmberg J; Bhattachariya A; Alajbegovic A; Rippe C; Ekman M; Dahan D; Hien TT; Boettger T; Braun T; Swärd K; Hellstrand P; Albinsson S
    Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):414-424. PubMed ID: 29217510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A rationale for treatment of endothelial dysfunction in hypertension.
    Ruschitzka F; Corti R; Noll G; Lüscher TF
    J Hypertens Suppl; 1999 Feb; 17(1):S25-35. PubMed ID: 10340841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular protection with newer antihypertensive agents.
    Schiffrin EL
    J Hypertens Suppl; 1998 Oct; 16(5):S25-9. PubMed ID: 9869001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin converting enzyme inhibition and vascular hypertrophy in hypertension.
    Gibbons GH; Dzau VJ
    Cardiovasc Drugs Ther; 1990 Feb; 4(1):237-42. PubMed ID: 2285616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitogen-activated protein kinase activity regulation role of angiotensin and endothelin systems in vascular smooth muscle cells.
    Kubo T; Ibusuki T; Chiba S; Kambe T; Fukumori R
    Eur J Pharmacol; 2001 Jan; 411(1-2):27-34. PubMed ID: 11137855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular angiotensin II as a regulator of muscle tone in vascular resistance vessels. Pathophysiological implications.
    De Mello WC
    Peptides; 2016 Apr; 78():87-90. PubMed ID: 26944358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular protection: current possibilities and future perspectives.
    Lüscher TF
    Int J Clin Pract Suppl; 2001 Jan; (117):3-6. PubMed ID: 11715356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanisms of vascular hypertrophy in hypertension].
    Tedgui A
    Arch Mal Coeur Vaiss; 1993 Jan; 86 Spec No 1():67-72. PubMed ID: 8215782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelin-1 released by vascular smooth muscle cells enhances vascular responsiveness of rat mesenteric arterial bed exposed to high perfusion flow.
    Russo D; Minutolo R; Clienti C; De Nicola L; Iodice C; Savino FA; Andreucci VE
    Am J Hypertens; 1999 Nov; 12(11 Pt 1):1119-23. PubMed ID: 10604489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin-converting enzyme inhibition and vascular structure in hypertension.
    Gibbons GH
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S19-24. PubMed ID: 1725196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade.
    Gschwend S; Henning RH; Pinto YM; de Zeeuw D; van Gilst WH; Buikema H
    Br J Pharmacol; 2003 Aug; 139(7):1317-25. PubMed ID: 12890711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Essential Role of Smooth Muscle STIM1 in Hypertension and Cardiovascular Dysfunction.
    Kassan M; Ait-Aissa K; Radwan E; Mali V; Haddox S; Gabani M; Zhang W; Belmadani S; Irani K; Trebak M; Matrougui K
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1900-9. PubMed ID: 27470514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.